Clinical Practice Guidelines for the management of locally advanced ...

8 Miller DC, Litwin MS, Bergman J, Stepanian S, Connor SE, Kwan L et al. Prostate cancer
severity among low income, uninsured men. J Urol 2009; 181(2):579–583.
9 Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN et al. Racial disparity and
socioeconomic status in association with survival in older men with local/regional stage
prostate carcinoma: findings from a large community-based cohort. Cancer 2006;
106(6):1276–1285.
10 Coory MD, Baade PD. Urban-rural differences in prostate cancer mortality, radical
prostatectomy and prostate-specific antigen testing in Australia. Med J Aust 2005;
182(3):112–115.
11 Jong KE, Smith DP, Yu XQ, O’Connell DL, Goldstein D, Armstrong BK. Remoteness of
residence and survival from cancer in New South Wales. Med J Aust 2004; 180(12):618–622.
12 Hayen A, Smith DP, Patel MI, O’Connell DL. Patterns of surgical care for prostate cancer in
NSW, 1993–2002: rural/urban and socio-economic variation. Aust N Z J Public Health 2008;
32(5):417–420.
13 Condon JR, Armstrong BK, Barnes A, Cunningham J. Cancer in Indigenous Australians: a
review. Cancer Causes Control 2003; 14(2):109–121.
14 Condon JR, Barnes T, Cunningham J, Armstrong BK. Long-term trends in cancer mortality
for Indigenous Australians in the Northern Territory. Med J Aust 2004; 180(10):504–507.
15 Powell IJ, Banerjee M, Novallo M, Sakr W, Grignon D, Wood DP et al. Prostate cancer
biochemical recurrence stage for stage is more frequent among African–American than white
men with locally advanced but not organ-confined disease. Urology 2000; 55(2):246–251.
16 Thompson I, Tangen C, Tolcher A, Crawford E, Eisenberger M, Moinpour C. Association of
African–American ethnic background with survival in men with metastatic prostate cancer. J
Natl Cancer Inst 2001; 93(3):219–225.
17 Evans S, Metcalfe C, Ibrahim F, Persad R, Ben-Shlomo Y. Investigating Black–White
differences in prostate cancer prognosis: A systematic review and meta-analysis. Int J Cancer
2008; 123(2):430–435.
18 Halabi S, Small EJ, Vogelzang NJ, Barrier RC, Jr., George SL, Gilligan TD. Impact of race
on survival in men with metastatic hormone-refractory prostate cancer. Urology 2004;
64(2):212–217.
19 Tewari A, Horninger W, Pelzer AE, Demers R, Crawford ED, Gamito EJ et al. Factors
contributing to the racial differences in prostate cancer mortality. BJU Int 2005; 96(9):1247–
1252.
20 Robbins AS, Yin D, Parikh-Patel A. Differences in prognostic factors and survival among
White men and Black men with prostate cancer, California, 1995–2004. Am J Epidemiol
2007; 166(1):71–78.
21 Gilligan T. Social disparities and prostate cancer: mapping the gaps in our knowledge. Cancer
Causes Control 2005; 16(1):45–53.
22 Supramaniam R, O’Connell DL, Tracey EA, Sitas F. Cancer Incidence in New South Wales
Migrants 1991 to 2001. Sydney: Cancer Council NSW, 2006.
23 Holden CA, Jolley DJ, McLachlan RI, Pitts M, Cumming R, Wittert G et al. Men in Australia
Telephone Survey (MATeS): predictors of men’s help-seeking behaviour for reproductive
health disorders. Med J Aust 2006; 185(8):418–422.
113
Socio-economic aspects of advanced prostate cancer